BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14968553)

  • 1. [Immunophilin FKBP38, an inherent inhibitor of calcineurin, targets Bcl-2 to mitochondria and inhibits apoptosis].
    Shirane M; Nakayama KI
    Nihon Rinsho; 2004 Feb; 62(2):405-12. PubMed ID: 14968553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis.
    Shirane M; Nakayama KI
    Nat Cell Biol; 2003 Jan; 5(1):28-37. PubMed ID: 12510191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of presenilins with FKBP38 promotes apoptosis by reducing mitochondrial Bcl-2.
    Wang HQ; Nakaya Y; Du Z; Yamane T; Shirane M; Kudo T; Takeda M; Takebayashi K; Noda Y; Nakayama KI; Nishimura M
    Hum Mol Genet; 2005 Jul; 14(13):1889-902. PubMed ID: 15905180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheb GTPase controls apoptosis by regulating interaction of FKBP38 with Bcl-2 and Bcl-XL.
    Ma D; Bai X; Zou H; Lai Y; Jiang Y
    J Biol Chem; 2010 Mar; 285(12):8621-7. PubMed ID: 20048149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria: FKBP38 and mitochondrial degradation.
    Shirane-Kitsuji M; Nakayama KI
    Int J Biochem Cell Biol; 2014 Jun; 51():19-22. PubMed ID: 24657651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of FK-506 binding protein 38 and its potential regulatory role on the anti-apoptotic protein Bcl-2.
    Kang CB; Feng L; Chia J; Yoon HS
    Biochem Biophys Res Commun; 2005 Nov; 337(1):30-8. PubMed ID: 16176796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuroprotective actions of FK506 binding protein ligands: neuronal survival is triggered by de novo RNA synthesis, but is independent of inhibition of JNK and calcineurin.
    Klettner A; Baumgrass R; Zhang Y; Fischer G; Bürger E; Herdegen T; Mielke K
    Brain Res Mol Brain Res; 2001 Dec; 97(1):21-31. PubMed ID: 11744159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The flexible loop of Bcl-2 is required for molecular interaction with immunosuppressant FK-506 binding protein 38 (FKBP38).
    Kang CB; Tai J; Chia J; Yoon HS
    FEBS Lett; 2005 Feb; 579(6):1469-76. PubMed ID: 15733859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FKBP38 protects Bcl-2 from caspase-dependent degradation.
    Choi BH; Feng L; Yoon HS
    J Biol Chem; 2010 Mar; 285(13):9770-9779. PubMed ID: 20139069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered Bad localization and interaction between Bad and Bcl-xL in the hippocampus after transient global ischemia.
    Abe T; Takagi N; Nakano M; Furuya M; Takeo S
    Brain Res; 2004 May; 1009(1-2):159-68. PubMed ID: 15120593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca2+/S100 proteins inhibit the interaction of FKBP38 with Bcl-2 and Hsp90.
    Shimamoto S; Tsuchiya M; Yamaguchi F; Kubota Y; Tokumitsu H; Kobayashi R
    Biochem J; 2014 Feb; 458(1):141-52. PubMed ID: 24295050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Drp1-dependent mitochondrial fragmentation and apoptosis by a polypeptide antagonist of calcineurin.
    Cereghetti GM; Costa V; Scorrano L
    Cell Death Differ; 2010 Nov; 17(11):1785-94. PubMed ID: 20489733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 regulator FKBP38 is activated by Ca2+/calmodulin.
    Edlich F; Weiwad M; Erdmann F; Fanghänel J; Jarczowski F; Rahfeld JU; Fischer G
    EMBO J; 2005 Jul; 24(14):2688-99. PubMed ID: 15990872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FKBP38-Bcl-2 interaction: a novel link to chemoresistance.
    Choi BH; Yoon HS
    Curr Opin Pharmacol; 2011 Aug; 11(4):354-9. PubMed ID: 21571591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrocarcin A inhibits mitochondrial functions of Bcl-2 and suppresses its anti-apoptotic activity.
    Nakashima T; Miura M; Hara M
    Cancer Res; 2000 Mar; 60(5):1229-35. PubMed ID: 10728681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy.
    Tomek M; Akiyama T; Dass CR
    J Pharm Pharmacol; 2012 Dec; 64(12):1695-702. PubMed ID: 23146031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N-terminus and alpha-5, alpha-6 helices of the pro-apoptotic protein Bax, modulate functional interactions with the anti-apoptotic protein Bcl-xL.
    Parikh N; Koshy C; Dhayabaran V; Perumalsamy LR; Sowdhamini R; Sarin A
    BMC Cell Biol; 2007 May; 8():16. PubMed ID: 17519046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD.
    Wang HG; Pathan N; Ethell IM; Krajewski S; Yamaguchi Y; Shibasaki F; McKeon F; Bobo T; Franke TF; Reed JC
    Science; 1999 Apr; 284(5412):339-43. PubMed ID: 10195903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis.
    Chu F; Borthakur A; Sun X; Barkinge J; Gudi R; Hawkins S; Prasad KV
    Apoptosis; 2004 Jan; 9(1):83-95. PubMed ID: 14739602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Bcl-2 regulator FKBP38-calmodulin-Ca2+ is inhibited by Hsp90.
    Edlich F; Erdmann F; Jarczowski F; Moutty MC; Weiwad M; Fischer G
    J Biol Chem; 2007 May; 282(21):15341-8. PubMed ID: 17379601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.